NCT03432741 2025-05-26Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerMayo ClinicPhase 1 Terminated17 enrolled
NCT00337259 2016-02-17Gemcitabine for Marginal Zone LymphomaAsan Medical CenterPhase 2 Terminated43 enrolled
NCT00293345 2013-09-303-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Completed30 enrolled
NCT00324597 2013-09-17AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaNational Cancer Institute (NCI)Phase 1 Unknown18 enrolled
NCT00019513 2012-03-23Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or LymphomasNational Institutes of Health Clinical Center (CC)Phase 1 Completed108 enrolled